Demand for Antimicrobial Susceptibility Testing in Japan
Key Insight
The demand for antimicrobial susceptibility testing in Japan is projected to grow from USD 180.0 million in 2025 to USD 234.9 million by 2035, at a CAGR of 2.7%. Instruments will dominate with a 40.0% market share, while sepsis will lead the application segment with a 17.0% share.